The Journey of SGLT2i at TJUH

In this Shared Learning session, speakers from Cardiology, Endocrinology and Pharmacy at Jefferson Health presented their quality improvement (QI) project focused on the uptake and usage of SGLT2i medications in patients with diabetes and cardiovascular disease. The speakers presented interim updates and results of the QI interventions implemented to date along with the challenges, barriers to usage, successes and next steps for the QI project.

Date: Wednesday, March 3, 2021

Christine Clancy, MSN, CRNP, CDE Jefferson Health Division of Endocrinology, Diabetes and Metabolic Diseases

Christine Clancy, MSN, CRNP, CDE Jefferson Health Division of Endocrinology, Diabetes and Metabolic Diseases

Mathew Francis, MD PGY 3 Department of Medicine Thomas Jefferson University

Mathew Francis, MD PGY 3 Department of Medicine Thomas Jefferson University

Yair Lev, MD Clinical Assistant Professor Cardiology Thomas Jefferson University

Yair Lev, MD Clinical Assistant Professor Cardiology Thomas Jefferson University

Eric Shiffrin, MD Assistant Clinical Professor Division of Endocrinology, Diabetes and Metabolic Diseases Thomas Jefferson University Hospital

Eric Shiffrin, MD Assistant Clinical Professor Division of Endocrinology, Diabetes and Metabolic Diseases Thomas Jefferson University Hospital